Amr Salama, MD
Cardiovascular Disease · Fresno, CANPI 1366825630
Payments from drug & device makers
Across 316 payments — averaging $195.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$24K
- Boston Scientific$18K
- Medtronic$16K
- Terumo Medical Corporation$1K
- Edwards Lifesciences$933
- Abiomed$526
- plus $2K from 18 others
Across 1 payment — averaging $49.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$50
What the payments were for
- Grants$52,36485%
- Travel & lodging$2,5944%
- Food & beverage$6,27510%
- Education$4501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 33 | $23,860 |
| Boston Scientific | 17 | $17,719 |
| Medtronic(2 entities) | 117 | $15,589 |
| Terumo Medical Corporation | 6 | $1,028 |
| Edwards Lifesciences | 49 | $933 |
| Abiomed | 12 | $526 |
| Astellas Pharma US Inc | 8 | $388 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 39 | $360 |
| Chiesi USA, Inc. | 4 | $183 |
| Boehringer Ingelheim | 4 | $177 |
| ZOLL Circulation Inc | 1 | $144 |
| Pfizer | 6 | $139 |
| Inari Medical, Inc. | 1 | $113 |
| Penumbra, Inc. | 2 | $111 |
| Angiodynamics, Inc. | 2 | $67 |
| E.r. Squibb & Sons, L.L.C. | 2 | $59 |
| AstraZeneca | 3 | $58 |
| Amgen | 3 | $55 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Cathworks, Inc. | 1 | $41 |
| Novartis | 2 | $33 |
| Atricure, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$11,370
- GLIDESHEATH SLENDER$1,003
- SAPIEN 3 Ultra RESILIA$293
- Impella$284
- WATCHMAN FLX$282
- NAVITOR$175
- TherOx DS2 Console$144
- Catheter$144
- Downstream Cartridge$144
- EnSite Precision Cardiac Mapping System$139
- WATCHMAN Access System$138
- JARDIANCE$125
- FLOWTRIEVER CATHETER, S$113
- CT THROMBECTOMY SYSTEM KIT$113
How this compares
$61,682 in reported general payments places this provider in the 85th percentile of 2,184 cardiovascular disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Fresno
- Ted LoveHillsborough$102.8M
- Matthew BudoffTorrance$11.3M
- Lori DanielsSan Diego$10.2M
- Paul KurthSanta Barbara$6.1M
- Michael BlumSan Francisco$5.5M
- Tony ChouSan Francisco$5.2M
- Jason RogersSacramento$5.1M
- Yu-Ping WangStanford$3.8M
- Yogesh PaliwalPomona$3.3M
- Farhad RafiiWest Hills$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.